Abstract:Primary CNS melanoma is rare, with atypical clinical and imaging manifestations, and diagnosis relies on pathologic tissue biopsy. There is no standard treatment option for primary CNS melanoma, with surgical resection being the first choice and postoperative adjuvant radiotherapy appearing to provide some survival benefit. Targeted therapies and immunotherapy may be potential treatment options for primary CNS melanoma, but there is still a lack of clinical studies in large samples of patients with primary CNS melanoma. The efficacy of multidisciplinary combination therapy for primary CNS melanoma may be better. Primary central nervous system (CNS) melanoma is an extremely rare condition, with an incidence rate of 0.01 per 100,000 individuals per year. Despite its rarity, the etiology and pathogenesis of this disease are not yet fully understood. Primary CNS melanoma exhibits highly aggressive biological behavior and presents clinically in a distinct manner from other types of melanomas. It can develop at any age, predominantly affecting the meninges as the primary site, with clinical symptoms varying depending on the neoplasm's location. Due to the lack of specificity in its presentation and the challenging nature of imaging diagnosis, distinguishing primary CNS melanoma from other CNS diseases. The combination of challenges in early detection, heightened tumor aggressiveness, and the obscured location of its origin contribute to an unfavorable prognostic outcome. Furthermore, there has been currently no consensus on a standardized treatment approach for primary CNS melanoma. Despite recent advancements in targeted therapy and immunotherapy for CNS melanoma, patients with primary CNS melanoma have limited treatment options due to their inadequate response to these therapies. Here, we provided a comprehensive summary of the epidemiology, clinical features, molecular pathological manifestations, and available diagnostic and therapeutic approaches of primary CNS melanoma. Additionally, we proposed potential therapeutic strategies for it.

Dioagnosis and Treatment of Central Nervous System Malignant Melanoma

Primary Melanocytoma of Central Nervous System:A Clinicopathologic Analysis of Two Cases

[Diagnosis and Treatment of Malignant Melanoma in Central Nervous System].

Primary sellar melanocytic tumor mimicking hemorrhagic pituitary macroadenoma: Case report and literature review.

Long-term Survival after Combined Modality Treatment of Primary Intracranial Malignant Melanoma: a Case Report and Review of the Literatures

Diagnosis and Treatment of Intracranial Malignant Melanoma:Clinical Analysis of 5 Cases and Review of the Literature

Clinicopathological features, current status, and progress of primary central nervous system melanoma diagnosis and treatment

Ultrastructural and Clinical Features of Central Nervous System Melanoma:Analysis of Nine Cases.

[Diagnosis and treatment of primary intraspinal melanocytoma].

[Diagnosis of Intracranial Malignant Melanoma].

Neurocutaneous Melanosis with an Intracranial Cystic-Solid Meningeal Melanoma in an Adult: A Case Report and Review of Literature

Clinical Characteristics and Treatment Outcomes of Pigmented Tumors in Central Nervous System: Focusing on Melanocytic Tumors

Path-43. Malignant Transformation Of Meningeal Melanocytoma - Genetic Alterations And Response To Checkpoint Blockade Immunotherapy

Diagnosis and treatment of central neurocytomas (a report of 8 cases)

Diagnosis and Treatment of 29 Cases with Primary Central Nervous System Lymphoma

Clinical Analysis of 8 Cases of Primary Cervical Malignant Melanoma

Surgical treatment of intracranial malignant melanoma: an anlysis of 7 cases

Diagnosis and Treatment of Sino-Nasal Malignant Melanoma: a Report of 37 Cases

Spinal meningeal melanocytomas: clinical manifestations, radiological and pathological characteristics, and surgical outcomes

The Diagnosis and Treatment of Orbital Malignant Melanoma

Clinical Diagnosis and Therapy of Intracranial Malignant Nerve Sheath Tumors